Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses

被引:23
作者
Landoni, MF [1 ]
Lees, P [1 ]
机构
[1] UNIV LONDON ROYAL VET COLL,DEPT VET BASIC SCI,HATFIELD AL9 7TA,HERTS,ENGLAND
关键词
D O I
10.1111/j.1365-2885.1995.tb00624.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The bioavailability of S(+) and R(-) ketoprofen (KTP) in six horses was investigated after oral administration of the racemic (rac) mixture. Two oral formulations were studied, an oil-based paste containing micronised rac-KTP and powder from the same source in hard gelatin capsules, each at a dose rate of 2.2 mg/kg. For the oil-based paste two feeding schedules were used; horses were either allowed free access to food or access to food was restricted for 4 h before and 5 h after dosing. The drug in hard gelatin capsules was administered to horses with restricted access to food, After intravenous administration of rac-KTP, S(+) enantiomer concentrations exceeded those of the R(-) enantiomer. For S(+) and R(-)KTP, respectively, pharmacokinetic parameters were, t(1/2 beta) 0.99 +/- 0.14 h, 0.70 +/- 0.13 h; Cl-B 0.56 +/- 0.09, 0.92 +/- 0.20 L/h/kg; V-d(ss) 0.53 +/- 0.11, 0.61 +/- 0.10 L/kg. Following oral administration of rac-KTP as the oil-based paste to horses with free access to food, there were no detectable concentrations in plasma in three animals at any sampling time, while a fourth animal showed very low concentrations at two sampling times only. In the two remaining horses very low but detectable concentrations were present for 5 h. In the horses with restricted access to food, rac-KTP paste administration produced higher concentrations in plasma. However, bioavailability was very low, 2.67 +/- 0.43 and 5.75 +/- 1.48% for R(-) and S(+)KTP, respectively. When administered as pure drug substance in hard gelatin capsules, absorption of KTP was fairly rapid, but incomplete. Bioavailability was 50.55 +/- 10.95 and 54.17 +/- 9.9% for R(-) and S(+)KTP, respectively. This study demonstrates that rac-KTP had a modest bioavailability when administered as a micronised powder in hard gelatin capsules to horses with restricted access to food. When powder from the same source was administered as an oil-based paste, it was for practical purposes not bioavailable, regardless of the feeding schedule.
引用
收藏
页码:446 / 450
页数:5
相关论文
共 17 条
[1]  
BAGGOT J D, 1978, Journal of Veterinary Pharmacology and Therapeutics, V1, P111, DOI 10.1111/j.1365-2885.1978.tb00314.x
[2]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF KETOPROFEN ENANTIOMERS IN HUMAN-PLASMA AND URINE [J].
FOSTER, RT ;
JAMALI, F .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 416 (02) :388-393
[3]   PHARMACOKINETICS OF PHENYLBUTAZONE AND ITS METABOLITES IN THE HORSE [J].
GERRING, EL ;
LEES, P ;
TAYLOR, JB .
EQUINE VETERINARY JOURNAL, 1981, 13 (03) :152-157
[4]  
GIBALDI M, 1982, PHARMACOKINETICS, P133
[5]  
Gibaldi M., 1984, BIOPHARMACEUTICS CLI, P17
[6]   ENANTIOSELECTIVE PHARMACOKINETICS OF KETOPROFEN IN HORSES [J].
JAUSSAUD, P ;
BELLON, C ;
BESSE, S ;
COURTOT, D ;
DELATOUR, P .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1993, 16 (03) :373-376
[7]  
JULOU L, 1983, SCANDINAVIAN J RHEUM, V14, P33
[8]  
LANDONI MF, 1995, IN PRESS EQUINE VET
[9]   ABSORPTION OF PHENYLBUTAZONE FROM A PASTE FORMULATION ADMINISTERED ORALLY TO THE HORSE [J].
LEES, P ;
HIGGINS, AJ ;
MAWHINNEY, IC ;
REID, DS .
RESEARCH IN VETERINARY SCIENCE, 1986, 41 (02) :200-206
[10]  
LEES P, 1988, RES VET SCI, V44, P50